Impact of introducing anticoagulation-related prescribing guidelines in a hospital setting using academic detailing
Authors Gregory William Roberts, Robert Adams
Published 15 September 2006 Volume 2006:2(3) Pages 309—316
Gregory William Roberts1, Robert Adams2
1Pharmacy Department, Repatriation General Hospital, Daws Road, Daw Park, SA, Australia; 2Department of Medicine, Queen Elizabeth Hospital, Woodville Road, Woodvillle, SA, Australia
Aim: Assess the impact of using academic detailing-assisted guideline roll-out on warfarin initiation, reversal of warfarin overanticoagulation, and uptake of deep vein thrombosis (DVT) prophylaxis across 4 metropolitan teaching hospitals.
Methods: Baseline data were collected for 3 months prior to intervention. Prescribers were then informed about the guidelines, including feedback of current hospital performance and the basis for the guidelines. Post-intervention data were collected for 3 months after guideline implementation.
Results: Uptake of DVT prophylaxis in medical patients increased from 52.8% to 67.0% (p=0.004). No impact on operative surgical patients was seen, possibly due to the high preexisting rate of uptake (86.1% vs 84.1%, p=0.7). DVT prophylaxis rates in non-operative surgical patients were similar to medical patients, with similar, but non-significant improvements. The time to reach a stable therapeutic international normalized ratio (INR) after warfarin initiation was reduced (p=0.03) as were the number of INR’s >4 in the first week of therapy (p=0.03). There were significant improvements in appropriate vitamin K use for warfarin overanticoagulation in patients with an INR above 6 (48% vs 74%, p=0.007), timely follow-up tests (49% vs 62%, p=0.009), and the proportion of next INR’s being less than 4 (49% vs 61%, p=0.04).
Conclusions: The use of academic detailing to facilitate guideline roll-out had a positive impact on nearly all areas studied. The academic detailing process within the hospital setting was received enthusiastically by prescribers.
Keywords: warfarin, overanticoagulation, DVT prophylaxis, elderly, academic detailing
Readers of this article also read:
Uram Ł, Szuster M, Gargasz K, Filipowicz A, Wałajtys-Rode E, Wołowiec S
Published Date: 11 December 2013
Rapidis A, Sarlis N, Lefebvre J-L, et al
Published Date: 5 December 2008
Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials
Kyoko Taku, Keizo Umegaki, Yoshiko Ishimi, Shaw Watanabe
Published Date: 10 October 2008
Lars Thomassen, Ulrike Waje-Andreassen, Halvor Naess
Published Date: 8 August 2008
Published Date: 11 April 2008
Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis
Published Date: 15 January 2008
Dimitrios G Fatouros, Ditte M Karpf, Flemming S Nielsen, Anette Mullertz
Published Date: 15 September 2007
Published Date: 15 July 2007
Exjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion
Maria Domenica Cappellini
Published Date: 15 May 2007
Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom
Anna Raber, Joan Heras, Joan Costa, Josep Fortea, Albert Cobos
Published Date: 15 May 2007